Atossa Genetics, Inc. (ATOS) - NASDAQ
Company Description
Atossa Genetics, Inc. is a clinical-stage pharmaceutical company, which focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer and other breast conditions. It offers two diagnostic tests: ForeCYTE and ArgusCYTE. The ForeCYTE Breast Health Test... More
Sector: Healthcare
Industry: Diagnostic Substances
Country: United States